Back to Search
Start Over
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
- Source :
- Journal of Clinical Oncology; 9/1/2023, Vol. 41 Issue 25, p4143-4153, 17p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 41
- Issue :
- 25
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 170897490
- Full Text :
- https://doi.org/10.1200/JCO.22.01420